发明公开
- 专利标题： HETEROCYCLIC COMPOUND
- 专利标题（中）： 杂环化合物
-
申请号： EP15834925.8申请日： 2015-08-25
-
公开(公告)号： EP3187497A1公开(公告)日： 2017-07-05
- 发明人: KAIEDA, Akira , ISHII, Naoki , NARA, Hiroshi , YOSHIKAWA, Masato , DAINI, Masaki , TOYOFUKU, Masashi , HIDAKA, Kousuke
- 申请人： Takeda Pharmaceutical Company Limited
- 申请人地址： 1-1 Doshomachi 4-chome Chuo-ku Osaka-shi, Osaka 541-0045 JP
- 专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人： Takeda Pharmaceutical Company Limited
- 当前专利权人地址： 1-1 Doshomachi 4-chome Chuo-ku Osaka-shi, Osaka 541-0045 JP
- 代理机构： Held, Stephan
- 优先权： JP2014172058 20140826
- 国际公布： WO2016031815 20160303
- 主分类号： C07D413/12
- IPC分类号： C07D413/12 ; A61K31/4245 ; A61K31/454 ; A61K31/4709 ; A61K31/4725 ; A61K31/496 ; A61K31/5377 ; A61K31/55 ; A61P29/00 ; A61P35/00 ; A61P37/06 ; A61P43/00 ; C07D413/14 ; C07D417/14 ; C07D471/04 ; C07D487/04 ; C07D491/107
摘要：
The present invention provides a heterocyclic compound having a HDAC inhibitory action, and useful for the treatment of autoimmune diseases and/or inflammatory diseases, graft versus host disease, cancers, central nervous diseases including neurodegenerative diseases and the like, and a medicament comprising the compound.
The present invention relates to a compound represented by the formula (I):
wherein each symbol is as defined in the specification, or a salt thereof.
The present invention relates to a compound represented by the formula (I):
wherein each symbol is as defined in the specification, or a salt thereof.
信息查询
